Selenium inhibits ferroptosis in hyperglycemic cerebral ischemia/reperfusion injury by stimulating the Hippo pathway
PLOS ONE · 08.09.2023 · 18 (9) · e0291192
DOI: 10.1371/journal.pone.0291192 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 08.09.2023. Verfasst von Lu Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ningxia Key Laboratory of Craniocerebral Diseases, Department of Pathology, School of Basic Medical Science, Ningxia Medical University, Yinchuan, Ni…. Hauptthemen laut MEDLINE: Selenium, Ferroptosis, Reperfusion Injury, Hyperglycemia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Ningxia, Natural Science Foundation of Ningxia.
Abstract (Originalsprache)
Hyperglycemia can exacerbate cerebral ischemia/reperfusion (I/R) injury, and the mechanism involves oxidative stress, apoptosis, autophagy and mitochondrial function. Our previous research showed that selenium (Se) could alleviate this injury. The aim of this study was to examine how selenium alleviates hyperglycemia-mediated exacerbation of cerebral I/R injury by regulating ferroptosis. Middle cerebral artery occlusion (MCAO) and reperfusion models were established in rats under hyperglycemic conditions. An in vitro model of hyperglycemic cerebral I/R injury was created with oxygen-glucose deprivation and reoxygenation (OGD/R) and high glucose was employed. The results showed that hyperglycemia exacerbated cerebral I/R injury, and sodium selenite pretreatment decreased infarct volume, edema and neuronal damage in the cortical penumbra. Moreover, sodium selenite pretreatment increased the survival rate of HT22 cells under OGD/R and high glucose conditions. Pretreatment with sodium selenite reduced the hyperglycemia mediated enhancement of ferroptosis. Furthermore, we observed that pretreatment with sodium selenite increased YAP and TAZ levels in the cytoplasm while decreasing YAP and TAZ levels in the nucleus. The Hippo pathway inhibitor XMU-MP-1 eliminated the inhibitory effect of sodium selenite on ferroptosis. The findings suggest that pretreatment with sodium selenite can regulate ferroptosis by activating the Hippo pathway, and minimize hyperglycemia-mediated exacerbation of cerebral I/R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ningxia Key Laboratory of Craniocerebral Diseases, Department of Pathology, School of Basic Medical Science, Ningxia Medical University, Yinchuan, Ningxia, China.
- The Shanghai Health Commission Key Lab of AI-Based Management of Inflammation and Chronic Diseases, The Gongli Hospital of Shanghai Pudong New Area, Shanghai, China.
ORCID-Profile: Lu Li
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Ningxia
- Natural Science Foundation of Ningxia
Zitieren
APA
Li, L., Wang, M., Ma, Y. M., Yang, L., Zhang, D. H., Guo, F. Y., Jing, L., & Zhang, J. Z. (2023). Selenium inhibits ferroptosis in hyperglycemic cerebral ischemia/reperfusion injury by stimulating the Hippo pathway. PLOS ONE, 18(9), e0291192. https://doi.org/10.1371/journal.pone.0291192
Vancouver
Li L, Wang M, Ma YM, Yang L, Zhang DH, Guo FY, et al. Selenium inhibits ferroptosis in hyperglycemic cerebral ischemia/reperfusion injury by stimulating the Hippo pathway. PLOS ONE. 2023;18(9):e0291192. doi:10.1371/journal.pone.0291192
BibTeX
@article{Li2023,
author = {Li, Lu and Wang, Meng and Ma, Yan-Mei and Yang, Lan and Zhang, Deng-Hai and Guo, Feng-Ying and Jing, Li and Zhang, Jian-Zhong},
title = {Selenium inhibits ferroptosis in hyperglycemic cerebral ischemia/reperfusion injury by stimulating the Hippo pathway},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {9},
pages = {e0291192},
doi = {10.1371/journal.pone.0291192}
}
EUVIMED